Literature DB >> 28938069

Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor.

Muhammad Rafehi1, Alexander Neumann1, Younis Baqi2, Enas M Malik1, Michael Wiese3, Vigneshwaran Namasivayam1,3, Christa E Müller1.   

Abstract

A homology model of the nucleotide-activated P2Y2R was created based on the X-ray structures of the P2Y1 receptor. Docking studies were performed, and receptor mutants were created to probe the identified binding interactions. Mutation of residues predicted to interact with the ribose (Arg110) and the phosphates of the nucleotide agonists (Arg265, Arg292) or that contribute indirectly to binding (Tyr288) abolished activity. The Y114F, R194A, and F261A mutations led to inactivity of diadenosine tetraphosphate and to a reduced response of UTP. Significant reduction in agonist potency was observed for all other receptor mutants (Phe111, His184, Ser193, Phe261, Tyr268, Tyr269) predicted to be involved in agonist recognition. An ionic lock between Asp185 and Arg292 that is probably involved in receptor activation interacts with the phosphate groups. The antagonist AR-C118925 and anthraquinones likely bind to the orthosteric site. The updated homology models will be useful for virtual screening and drug design.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28938069     DOI: 10.1021/acs.jmedchem.7b00854

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y2 antagonist.

Authors:  Markie O Muoboghare; Robert M Drummond; Charles Kennedy
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

2.  Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists.

Authors:  Markie O Dales; Callum Mitchell; Alison M Gurney; Robert M Drummond; Charles Kennedy
Journal:  Purinergic Signal       Date:  2022-08-26       Impact factor: 3.950

3.  Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits.

Authors:  Jan Hendrik Voss; Andhika B Mahardhika; Asuka Inoue; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-03

4.  Nucleic acid ligands act as a PAM and agonist depending on the intrinsic ligand binding state of P2RY2.

Authors:  Masaki Takahashi; Ryo Amano; Michiru Ozawa; Anna Martinez; Kazumasa Akita; Yoshikazu Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

Review 5.  Update of P2Y receptor pharmacology: IUPHAR Review 27.

Authors:  Kenneth A Jacobson; Esmerilda G Delicado; Christian Gachet; Charles Kennedy; Ivar von Kügelgen; Beibei Li; M Teresa Miras-Portugal; Ivana Novak; Torsten Schöneberg; Raquel Perez-Sen; Doreen Thor; Beili Wu; Zhenlin Yang; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-04-06       Impact factor: 9.473

6.  Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease.

Authors:  Benjamin M Scott; Cristina Gutiérrez-Vázquez; Liliana M Sanmarco; Jessica A da Silva Pereira; Zhaorong Li; Agustín Plasencia; Patrick Hewson; Laura M Cox; Madelynn O'Brien; Steven K Chen; Pedro M Moraes-Vieira; Belinda S W Chang; Sergio G Peisajovich; Francisco J Quintana
Journal:  Nat Med       Date:  2021-06-28       Impact factor: 53.440

Review 7.  In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.

Authors:  Veronica Salmaso; Kenneth A Jacobson
Journal:  Biomolecules       Date:  2020-05-26

8.  Cell-permeable high-affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors.

Authors:  Markus Kuschak; Vigneshwaran Namasivayam; Muhammad Rafehi; Jan H Voss; Jaspal Garg; Jonathan G Schlegel; Aliaa Abdelrahman; Stefan Kehraus; Raphael Reher; Jim Küppers; Katharina Sylvester; Sonja Hinz; Michaela Matthey; Daniela Wenzel; Bernd K Fleischmann; Alexander Pfeifer; Asuka Inoue; Michael Gütschow; Gabriele M König; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

Review 9.  Recommended tool compounds and drugs for blocking P2X and P2Y receptors.

Authors:  Christa E Müller; Vigneshwaran Namasivayam
Journal:  Purinergic Signal       Date:  2021-09-02       Impact factor: 3.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.